#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14224	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2134	664.0	0	.	n	.	0	C451T	SNP	451	451	C	760	760	T	803	T,C	746,4	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14224	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2134	664.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1493	1493	C	815	C,A	748,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26014	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3545	731.2	0	.	n	.	0	T695C	SNP	695	695	T	1119	1119	C	776	C	719	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26014	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3545	731.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2395	2395	C	800	C,T	734,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26014	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3545	731.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2469	2469	A	755	A	715	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26014	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3545	731.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3021	3021	C	808	C	748	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26014	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3545	731.2	0	HET	.	.	.	A1638G	.	1638	1638	A	2062	2062	A	842	A,G	601,176	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1876	folP	855	855	100.0	folP.l6.c30.ctg.1	1409	132.1	1	SNP	p	R229S	1	.	.	685	687	AGC	976	978	AGC	182;184;187	A;G;C	172;171;172	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5198	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3490	148.7	1	SNP	p	S91F	1	.	.	271	273	TTC	630	632	TTC	179;181;178	T;T;C	165;163;163	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5198	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3490	148.7	1	SNP	p	G95N	0	.	.	283	285	GGC	642	644	GGC	166;166;167	G;G;C,A	150;149;149,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5198	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3490	148.7	1	SNP	p	D95G	1	.	.	283	285	GGC	642	644	GGC	166;166;167	G;G;C,A	150;149;149,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1700	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1186	142.8	1	SNP	p	G45D	0	.	.	133	135	GGC	453	455	GGC	208;213;217	G;G;C	196;200;201	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	826	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	941	87.3	0	.	n	.	0	A197.	DEL	197	197	A	547	547	A	199	A	184	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4962	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2948	167.8	1	SNP	p	D86N	0	.	.	256	258	GAC	559	561	GAC	218;217;215	G,T,C;A;C	196,1,1;197;199	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4962	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2948	167.8	1	SNP	p	S87R	1	.	.	259	261	CGT	562	564	CGT	217;216;219	C;G;T	202;200;200	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4962	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2948	167.8	1	SNP	p	R87I	0	.	.	259	261	CGT	562	564	CGT	217;216;219	C;G;T	202;200;200	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4962	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2948	167.8	1	SNP	p	R87W	0	.	.	259	261	CGT	562	564	CGT	217;216;219	C;G;T	202;200;200	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4962	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2948	167.8	1	SNP	p	S88P	0	.	.	262	264	TCC	565	567	TCC	220;218;220	T;C;C	200;199;199	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4044	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2579	156.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1500	1502	GGC	190;189;189	G;G;C	168;164;166	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1259	1261	GCC	185;185;183	G;C;C	171;171;170	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1262	1264	ATG	182;185;188	A,G;T;G	168,1;171;175	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1274	1276	ACC	192;192;191	A;C;C	174;179;176	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1274	1276	ACC	192;192;191	A;C;C	174;179;176	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1775	1777	ACC	220;214;215	A;C;C	196;195;197	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1829	1831	GCG	199;198;197	G;C;G	178;176;177	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1829	1831	GCG	199;198;197	G;C;G	178;176;177	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1952	1954	GGT	181;185;184	G;G;T	167;170;164	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1961	1963	AGC	180;180;177	A;G;C	162;162;161	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3784	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2421	155.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1979	1981	CCG	157;159;158	C,G;C,G;G	113,10;117,1;121	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5570	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3094	179.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1608	1610	CCG	201;197;199	C;C;G	176;181;172	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2088	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1882	110.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	595	595	C	159	C	141	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	2610	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	G48E	NONSYN	142	144	GGA	447	449	GAA	208;207;214	G;A,G;A	198;161,40;203	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	2610	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	933	935	AGA	216;216;221	A;G;A	198;194;196	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	2610	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	954	956	GGT	214;218;218	G;G;T	200;202;199	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	2610	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1470	175.2	1	SNP	p	G120K	1	.	.	358	360	AAG	663	665	AAG	199;201;199	A;A;G	185;188;180	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	2610	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1470	175.2	1	SNP	p	A121N	1	.	.	361	363	AAC	666	668	AAC	203;204;203	A;A;C	186;189;189	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	2610	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1470	175.2	1	SNP	p	N121D	0	.	.	361	363	AAC	666	668	AAC	203;204;203	A;A;C	186;189;189	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10446	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4814	216.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1118	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1179	94.7	1	SNP	p	V57M	1	.	.	169	171	ATG	481	483	ATG	223;222;223	A;T;G	206;206;204	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
